AERO CAD Study Evaluating the Shockwave C2 Aero IVL System in Coronary Artery Disease (NCT07512206)
AERO CAD: A Prospective, Multi-Center, Single-Arm Study Evaluating the Shockwave C2 Aero Coronary IVL System in Calcified Coronary Artery Disease
🩺 Plain-English Summary (8th-Grade Level)
The AERO CAD study is a prospective, multi-center, single-arm, post-market clinical investigation evaluating the procedural performance and clinical outcomes of the Shockwave C2 Aero Coronary Intravascular Lithotripsy (IVL) System in patients with calcified coronary artery disease undergoing percutaneous coronary intervention (PCI). The study will enroll up to 200 subjects across up to 8 U.S. sites. The primary objective is to generate real-world evidence on device performance and clinical outcomes, including target lesion failure at 30 days and procedural success.
Who can join: Review the eligibility criteria below.
Location: Los Robles Regional Medical Center — Thousand Oaks, California
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (8 Sites)
- Los Robles Regional Medical Center — Thousand Oaks, California
- Henry Ford St. John Hospital — Detroit, Michigan
- Jersey Shore University Medical Center — Neptune City, New Jersey
- The Valley Hospital — Paramus, New Jersey
- St Francis Hospital & Heart Center — Roslyn, New York
- Good Samaritan University Hospital — West Islip, New York
- WellSpan Health, York Hospital — York, Pennsylvania
- Baylor Scott & White Health - The Heart Hospital Plano — Plano, Texas
📞 Contact the Study Coordinator
Phone: (718) 753-4862
Email: fernando.sosa@opci.live
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Coronary Artery Disease (CAD)
- A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery. — Rochester, Minnesota
- Epicardial Delivery of XC001 Gene Therapy to Promote Angiogenesis in CAD Patients Undergoing Treatment With CABG — Cincinnati, Ohio
- Analysis of ECGio to Predict Coronary Stenosis Against a Mixed Reference Standard — Washington D.C., District of Columbia
- The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI — Marietta, Georgia
- Using CTA Measures to Define Cardiac Risk In NFL Alumni — Greenwood Village, Colorado
Explore by condition: All Coronary Artery Disease (CAD) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.